203 related articles for article (PubMed ID: 6757562)
1. [Mechanism of the antidiabetic action of sulfanylurea derivatives].
Iaroshevskiĭ IuA; Volkova EA
Klin Med (Mosk); 1982 Oct; 60(10):94-7. PubMed ID: 6757562
[No Abstract] [Full Text] [Related]
2. Clinical and metabolic observations with a new synthetic oral antidiabetic agent, glipizide.
D'Onofrio F; Pempinello R; Romis L
Arzneimittelforschung; 1972 Nov; 22(11):1879-81. PubMed ID: 4679059
[No Abstract] [Full Text] [Related]
3. [Blood sugar, serum insulin, nonesterified fatty acids and somatotropin in daily profile in adult diabetics under monotherapy with various sulfonylureas].
Happ J; Beyer J; Nest E; Fröhlich A; Althoff PH; Schöffling K
Arzneimittelforschung; 1974 Aug; 24(8):1228-34. PubMed ID: 4214173
[No Abstract] [Full Text] [Related]
4. Circadian variations of carbohydrate tolerance in maturity onset diabetics treated with sulfonylureas.
Göschke H; Denes A; Girard J; Collard F; Berger W
Horm Metab Res; 1974 Sep; 6(5):386-91. PubMed ID: 4417576
[No Abstract] [Full Text] [Related]
5. Plasma glucagon and clinical control of maturity-onset type diabetes. Effects of diet, placebo and glipizide.
Lecomte MJ; Luyckx AS; Lefebvre PJ
Diabete Metab; 1977 Dec; 3(4):239-43. PubMed ID: 340296
[No Abstract] [Full Text] [Related]
6. A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
Iacono G; Ghionni A; Colucci M; Verde G; Caputo G
Int J Clin Pharmacol; 1974 Apr; 7(3):225-31. PubMed ID: 4850166
[No Abstract] [Full Text] [Related]
7. [Changes in blood glucose, insulin, cortisol, growth hormone and glucagon induced by sulfonylures].
Haupt E; Petzoldt R; Treiber J; Schöffling K
Med Welt; 1982 Jan; 33(1):71-7. PubMed ID: 7035788
[No Abstract] [Full Text] [Related]
8. [Mechanism of action of gliquidone (author's transl)].
Zilker T; Ermler R; Henderkott U; Bottermann P
Dtsch Med Wochenschr; 1975 Aug; 100(35):1733-4, 1739-41. PubMed ID: 808405
[TBL] [Abstract][Full Text] [Related]
9. [Changes in fatty tissue sensitivity to insulin in the process of diabetes mellitus compensation using sulfanilurea derivatives].
Volkova EA; Iaroshevskiĭ IuA
Probl Endokrinol (Mosk); 1983; 29(3):13-7. PubMed ID: 6346316
[TBL] [Abstract][Full Text] [Related]
10. [Therapeutic trial of a new antidiabetic with vascular action: 1702 SE].
Jaillard J; Warembourg H
Lille Med; 1972 Oct; 17(9):Suppl 6:1332-6. PubMed ID: 4657429
[No Abstract] [Full Text] [Related]
11. [Glurenorm a new peroral antidiabetic agent belonging to the group of sulfonylurea compounds].
Grujić M; Rizvanbegović B; Perinović M; Perinović ID
Med Arh; 1976; 30(2):119-21. PubMed ID: 971371
[No Abstract] [Full Text] [Related]
12. [Treatment of diabetes mellitus with glibornurid].
Vignati E; Liuzzi A; Chiodini PG
Minerva Med; 1973 Oct; 64(75):3900-6. PubMed ID: 4767761
[No Abstract] [Full Text] [Related]
13. [Diabetes therapy with a new antidiabetic Pro-Diaban].
Dols W
Ther Ggw; 1976 Mar; 115(3):428-36. PubMed ID: 772866
[No Abstract] [Full Text] [Related]
14. [Insulin, glucose and free fatty acids in the serum of healthy and diabetic subjects following solitary oral dose of the sulfonylurea derivative glibornuride].
Herrlinger H; Dörfler H; Wolfram G; Zöllner N
Verh Dtsch Ges Inn Med; 1971; 77():550-2. PubMed ID: 5155895
[No Abstract] [Full Text] [Related]
15. [Gliclazide, a new antidiabetic with hemobiologic and vascular properties].
Plauchu M; Pousset G
Lyon Med; 1972 Oct; 228(16):383-5. PubMed ID: 4637685
[No Abstract] [Full Text] [Related]
16. A new antidiabetic agent.
Gupta SD; Mukerjee AB
J Indian Med Assoc; 1974 Dec; 63(11):357-9. PubMed ID: 4282091
[No Abstract] [Full Text] [Related]
17. [Regadrin treatment of diabetes mellitus].
Hohlfeld R; Neugebauer A; Haaser B; Marek H; Reuter W
Z Gesamte Inn Med; 1973 May; 28(10):Suppl 10:154-6. PubMed ID: 4734038
[No Abstract] [Full Text] [Related]
18. [Clinical study of a new sulfonylurea antidiabetic, glibornuride].
Vernet A; Fabre J; Zahnd G
Schweiz Rundsch Med Prax; 1972 Dec; 61(52):1599-607. PubMed ID: 4630563
[No Abstract] [Full Text] [Related]
19. [Study on Gliclazide, an antidiabetic with a double vascular and metabolic polarity].
Simonin R
Mars Med; 1972; 109(10):655-8. PubMed ID: 4659845
[No Abstract] [Full Text] [Related]
20. [Glibornurid in treatment of diabetes mellitus].
Rojszykowa E; Wrzesimski W
Pol Tyg Lek; 1974 Jan; 29(2):63-6. PubMed ID: 4820789
[No Abstract] [Full Text] [Related]
[Next] [New Search]
